|
US3755560A
(en)
|
1971-06-30 |
1973-08-28 |
Dow Chemical Co |
Nongreasy cosmetic lotions
|
|
US3929678A
(en)
|
1974-08-01 |
1975-12-30 |
Procter & Gamble |
Detergent composition having enhanced particulate soil removal performance
|
|
US4421769A
(en)
|
1981-09-29 |
1983-12-20 |
The Procter & Gamble Company |
Skin conditioning composition
|
|
US4666828A
(en)
|
1984-08-15 |
1987-05-19 |
The General Hospital Corporation |
Test for Huntington's disease
|
|
US4683202A
(en)
|
1985-03-28 |
1987-07-28 |
Cetus Corporation |
Process for amplifying nucleic acid sequences
|
|
US4801531A
(en)
|
1985-04-17 |
1989-01-31 |
Biotechnology Research Partners, Ltd. |
Apo AI/CIII genomic polymorphisms predictive of atherosclerosis
|
|
US4929442A
(en)
*
|
1986-09-26 |
1990-05-29 |
Exovir, Inc. |
Compositions suitable for human topical application including a growth factor and/or related materials
|
|
US5124155A
(en)
|
1988-06-21 |
1992-06-23 |
Chiron Ophthalmics, Inc. |
Fibronectin wound-healing dressings
|
|
US5272057A
(en)
|
1988-10-14 |
1993-12-21 |
Georgetown University |
Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase
|
|
US5264214A
(en)
|
1988-11-21 |
1993-11-23 |
Collagen Corporation |
Composition for bone repair
|
|
US5192659A
(en)
|
1989-08-25 |
1993-03-09 |
Genetype Ag |
Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes
|
|
US5073372A
(en)
|
1990-11-30 |
1991-12-17 |
Richardson-Vicks, Inc. |
Leave-on facial emulsion compositions
|
|
US5073371A
(en)
|
1990-11-30 |
1991-12-17 |
Richardson-Vicks, Inc. |
Leave-on facial emulsion compositions
|
|
US5564345A
(en)
*
|
1993-05-11 |
1996-10-15 |
Park Ohio Industries Inc. |
Stackable table, table assembly, and tray and table combination
|
|
EP0673384A4
(en)
*
|
1992-12-10 |
1996-10-09 |
Univ Minnesota |
POLYPEPTIDES USEFUL IN TREATING INFLAMMABLE DISEASES.
|
|
GB9315810D0
(en)
*
|
1993-07-30 |
1993-09-15 |
Univ London |
Stabilised materials
|
|
US7112320B1
(en)
*
|
1995-06-07 |
2006-09-26 |
Andre Beaulieu |
Solid wound healing formulations containing fibronectin
|
|
US6458889B1
(en)
*
|
1995-12-18 |
2002-10-01 |
Cohesion Technologies, Inc. |
Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and use
|
|
US6007802A
(en)
|
1996-03-27 |
1999-12-28 |
The Procter & Gamble Co. |
Conditioning shampoo composition
|
|
WO1998040045A1
(fr)
*
|
1997-03-11 |
1998-09-17 |
Pola Chemical Industries Inc. |
Procede d'evaluation d'agents de revitalisation et procede de production de preparations externes pour la peau
|
|
CA2232855C
(en)
*
|
1997-04-10 |
2007-10-09 |
Roche Consumer Health (Worldwide) Sa |
Pharmaceutical formulation
|
|
WO1999032135A1
(en)
*
|
1997-12-22 |
1999-07-01 |
Human Genome Sciences, Inc. |
Keratinocyte growth factor-2 formulations
|
|
US6194378B1
(en)
*
|
1998-02-18 |
2001-02-27 |
The Research Foundation Of State University Of New York |
Fibronectin peptides-based extracellular matrix for wound healing
|
|
GB9804720D0
(en)
|
1998-03-05 |
1998-04-29 |
Unilever Plc |
Shampoo compositions
|
|
AU5390699A
(en)
|
1998-07-24 |
2000-02-14 |
Pharmacal Biotechnologies, Inc. |
Osseous tissue reconstruction system and method
|
|
US20020006418A1
(en)
*
|
1998-10-13 |
2002-01-17 |
John Kung |
Composition to enhance permeation of topical skin agents
|
|
US20070129282A1
(en)
|
1998-11-24 |
2007-06-07 |
Ahlem Clarence N |
Pharmaceutical treatments and compositions
|
|
US20030072737A1
(en)
|
2000-12-29 |
2003-04-17 |
Michael Brines |
Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs
|
|
US6960173B2
(en)
|
2001-01-30 |
2005-11-01 |
Eilaz Babaev |
Ultrasound wound treatment method and device using standing waves
|
|
US6585963B1
(en)
*
|
2001-02-15 |
2003-07-01 |
Watson Pharmaceuticals, Inc. |
Nail compositions and methods of administering same
|
|
US6913762B2
(en)
|
2001-04-25 |
2005-07-05 |
Mayo Foundation For Medical Education And Research |
Stent having non-woven framework containing cells
|
|
US20030147825A1
(en)
*
|
2001-06-08 |
2003-08-07 |
Chiarelli Joseph A. |
Personal care compostions containing inverse emulsion polymers
|
|
US20030068297A1
(en)
*
|
2001-08-18 |
2003-04-10 |
Deepak Jain |
Composition and methods for skin rejuvenation and repair
|
|
US20040265268A1
(en)
|
2001-08-18 |
2004-12-30 |
Deepak Jain |
Compositions and methods for skin rejuvenation and repair
|
|
US7651684B2
(en)
|
2001-12-07 |
2010-01-26 |
Cytori Therapeutics, Inc. |
Methods of using adipose tissue-derived cells in augmenting autologous fat transfer
|
|
US7622299B2
(en)
|
2002-02-22 |
2009-11-24 |
University Of Washington |
Bioengineered tissue substitutes
|
|
JPWO2003103703A1
(ja)
|
2002-06-06 |
2005-10-06 |
中外製薬株式会社 |
骨代謝疾患治療剤
|
|
JP5144876B2
(ja)
|
2002-06-20 |
2013-02-13 |
バーダー、アウグスティヌス |
増殖因子を用いて、および生物学的マトリクスあるいは支持構造を用いて細胞を増殖および分化する方法およびデバイス
|
|
DE10234192B4
(de)
*
|
2002-07-26 |
2009-11-26 |
Epoplus Gmbh Co.Kg |
Verwendung von Erythropoetin
|
|
DE10303584A1
(de)
|
2003-01-30 |
2004-08-12 |
Stauss, Robert, Dr. |
Verwendung von Erythropoietin (EPO) als ein Beschichtungsmaterial auf medizinischen Implantaten
|
|
NZ542501A
(en)
|
2003-02-24 |
2009-09-25 |
Marinepolymer Tech Inc |
Compositions comprising chitin or chitosan and use thereof
|
|
US7459152B2
(en)
|
2003-04-23 |
2008-12-02 |
Rush University Medical Center |
Erythropoietin administration to improve graft survival
|
|
WO2005037304A1
(en)
*
|
2003-10-17 |
2005-04-28 |
Crucell Holland B.V. |
Treatment and prevention of decubitus
|
|
US20050148512A1
(en)
|
2003-11-10 |
2005-07-07 |
Angiotech International Ag |
Medical implants and fibrosis-inducing agents
|
|
AU2004309083B2
(en)
|
2003-12-30 |
2010-11-11 |
Augustinus Bader |
Tissue regeneration method
|
|
EP1550715A1
(de)
|
2003-12-30 |
2005-07-06 |
Bionethos Holding Gmbh |
Verfahren zur Regenation von Gewebe
|
|
WO2005070451A1
(en)
*
|
2004-01-22 |
2005-08-04 |
Zafena Aktiebolag |
Pharmaceutical composition comprising non-glycosylated erythropoietin
|
|
DE102004063927A1
(de)
*
|
2004-01-23 |
2005-12-15 |
Epoplus Gmbh Co.Kg |
Einsatz von niedrig dosiertem Erythropoietin zur Stimulation endothelialer Vorläuferzellen sowie zur Organregeneration und Progressionsverlangsamung von Endorganschäden
|
|
US7473678B2
(en)
|
2004-10-14 |
2009-01-06 |
Biomimetic Therapeutics, Inc. |
Platelet-derived growth factor compositions and methods of use thereof
|
|
EP1865982A1
(en)
*
|
2005-04-06 |
2007-12-19 |
Bioartificial Gel Technologies Inc. |
Hydrogel composition for modulation of topical inflammatory response
|
|
DE102005019712A1
(de)
*
|
2005-04-28 |
2006-11-09 |
Bayer Healthcare Ag |
Dipyridyl-dihydropyrazolone und ihre Verwendung
|
|
JP2008540513A
(ja)
*
|
2005-05-10 |
2008-11-20 |
ダーミプソル リミテッド |
スキンケアのための組成物及び方法
|
|
US7312198B2
(en)
*
|
2005-07-12 |
2007-12-25 |
Essential Skincare, Llc |
Protein compositions for promoting wound healing and skin regeneration
|
|
EP1942928A2
(en)
|
2005-10-31 |
2008-07-16 |
Essential Skincare, LLC |
Protein composition for promoting wound healing and skin regeneration
|
|
WO2007087402A2
(en)
|
2006-01-24 |
2007-08-02 |
Brown University |
Cell aggregation and encapsulation device and method
|
|
AU2007285483B2
(en)
*
|
2006-05-11 |
2011-12-22 |
Regenics As |
Administration of cells and cellular extracts for rejuvenation
|
|
TWI409081B
(zh)
*
|
2006-11-09 |
2013-09-21 |
Alcon Res Ltd |
用於藥物輸送之水不溶性聚合物基質
|
|
US7717855B2
(en)
*
|
2006-12-06 |
2010-05-18 |
The Hospital For Sick Children |
System for performing remote ischemic preconditioning
|
|
EP2337544A2
(en)
*
|
2007-04-30 |
2011-06-29 |
Living Proof, Inc. |
Use of matrix metalloproteinase inhibitors in skin care
|
|
BRPI0812718A2
(pt)
|
2007-06-19 |
2014-12-23 |
Baxter Int |
Métodos para modificar a liberação de uma proteína do fator de crescimento derivado de plaqueta, para modificar a liberação de um fator de crescimento derivado de plaqueta, para a liberação de uma proteína do fator de crescimento derivado de plaqueta e para tratar um paciente que sobre de um distúrbio ou doença, kit, e, uso de um selante de fibrina
|
|
EP2018835B1
(de)
*
|
2007-07-09 |
2014-03-05 |
Augustinus Bader |
Wirkstoff abgebendes Pflaster
|
|
US20090045968A1
(en)
|
2007-08-16 |
2009-02-19 |
Optimal Innovations Inc. |
Utility Outlets Capable of Presenting Images
|
|
US9101586B2
(en)
|
2007-12-28 |
2015-08-11 |
Augustine Bader |
Topical application and formulation of erythropoietin for skin wound healing
|
|
US20100310626A1
(en)
|
2008-01-24 |
2010-12-09 |
Remedor Biomed Ltd. |
Erythropoietin and fibronectin compositions for bone regeneration
|